Bankole Johnson

Bankole A.
Johnson is the founder of Adial Pharmaceuticals, Inc. (founded in 2010) and holds the title of Chief Medical Officer.
Dr. Johnson's current job(s) include being a Member of the American Psychiatric Association (since 2000), a Member of the New York Academy of Sciences (since 1994), a Member of the Society For Neuroscience (since 1995), a Member of The American College of Forensic Examiners (since 1999), a Member of the Society of Biological Psychiatry (since 2001), a Member of the American Society of Clinical Psychopharmacology (since 1995), a Professor-Anatomy & Neurobiology at the University of Maryland School of Medicine (since 2013), a Member of the American Board of Disability Analysts (since 2015), a Member of the American College of Neuropsychopharmacology (since 1999), a Member of the National Academy of Neuropsychology (since 2007), a Member of the College on Problems of Drug Dependence, Inc. (since 1997), a Member of the Old Dominion Medical Society (since 2007), a Member of the International Society For Biomedical Research On Alcoholism (since 2003), a Member of the Research Society On Alcoholism (since 1995), a Member of the British Neuropsychiatry Association Ltd.
(since 1989), and a Member of the British Association For Psychopharmacology (since 1986).
Dr. Johnson's former job(s) include being the Deputy Chairman-Research & Professor-Psychiatry at the University of Texas Health Science Center At San Antonio (from 1998 to 2004), a Professor-Medicine & Psychiatry Department at the University of Virginia (from 2004 to 2013), and a Member of the Association for Psychological Science.
Dr. Johnson's education history includes a doctorate degree from the University of Glasgow (conferred in 2004), a doctorate degree from the University of Glasgow (conferred in 1982), and a graduate degree from the University of London (conferred in 1991).